Aino Health AB (AINO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aino Health AB (AINO) has a cash flow conversion efficiency ratio of 0.211x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-593.00K ≈ $-63.82K USD) by net assets (Skr-2.81 Million ≈ $-302.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AINO cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Aino Health AB - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Aino Health AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aino Health AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aino Health AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Enorama Pharma AB
ST:ERMA
|
0.330x |
|
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB
|
-0.223x |
|
Fuller Smith & Turner
LSE:FSTA
|
0.093x |
|
Card Factory PLC
LSE:CARD
|
0.063x |
|
Omega Therapeutics Inc
NASDAQ:OMGA
|
-1.214x |
|
Calidi Biotherapeutics Inc.
NYSE MKT:CLDI
|
-1.342x |
|
Zotefoams PLC
LSE:ZTF
|
0.169x |
|
Roolife Group Ltd
AU:RLG
|
-0.550x |
Annual Cash Flow Conversion Efficiency for Aino Health AB (2014–2024)
The table below shows the annual cash flow conversion efficiency of Aino Health AB from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see AINO market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr-458.00K ≈ $-49.29K |
Skr-4.55 Million ≈ $-489.44K |
9.930x | +34.97% |
| 2023-12-31 | Skr-851.00K ≈ $-91.58K |
Skr-6.26 Million ≈ $-673.78K |
7.357x | +27.68% |
| 2022-12-31 | Skr-2.23 Million ≈ $-240.41K |
Skr-12.87 Million ≈ $-1.39 Million |
5.762x | +283.03% |
| 2021-12-31 | Skr2.58 Million ≈ $277.33K |
Skr-8.11 Million ≈ $-873.09K |
-3.148x | -317.78% |
| 2020-12-31 | Skr16.02 Million ≈ $1.72 Million |
Skr-12.07 Million ≈ $-1.30 Million |
-0.754x | -1.18% |
| 2019-12-31 | Skr14.47 Million ≈ $1.56 Million |
Skr-10.78 Million ≈ $-1.16 Million |
-0.745x | -36.68% |
| 2018-12-31 | Skr29.86 Million ≈ $3.21 Million |
Skr-16.27 Million ≈ $-1.75 Million |
-0.545x | +53.77% |
| 2017-12-31 | Skr21.96 Million ≈ $2.36 Million |
Skr-25.89 Million ≈ $-2.79 Million |
-1.179x | -1994.67% |
| 2016-12-31 | Skr53.33 Million ≈ $5.74 Million |
Skr-3.00 Million ≈ $-322.96K |
-0.056x | -156.22% |
| 2015-12-31 | Skr1.98 Million ≈ $212.86K |
Skr198.00K ≈ $21.31K |
0.100x | +103.48% |
| 2014-12-31 | Skr407.00K ≈ $43.80K |
Skr-1.17 Million ≈ $-126.02K |
-2.877x | -- |
About Aino Health AB
Aino Health AB (publ) develops and provides digital SaaS platforms and consulting services focused on workplace health management and operational efficiency for organizations. It offers HealthManager, a cloud-based system that supports company management in monitoring employee well-being, managing staff turnover, and reducing sick leave, while ensuring compliance with regulations such as GDPR. Th… Read more